Lab Reference Library / Phthalate Metabolites (Urinary) Advanced & Specialty

Phthalate Metabolites (Urinary)

Q: What are phthalates and where are they found?

Phthalates are a family of chemical plasticizers added to PVC plastic to increase flexibility, and are used as solvents and fixatives in personal care products, fragrances, and medications. The most common exposures come from food packaged in PVC containers, personal care products (shampoo, lotions, fragrances), soft plastic toys, vinyl flooring, medical tubing, and medications with enteric coatings.

Q: Can phthalates affect thyroid function?

Yes. Several phthalate metabolites, particularly MEHP (from DEHP), compete with thyroid hormone for binding to thyroid hormone transport proteins (TBG, TTR), reducing free T4 and T3 availability. They also inhibit thyroid peroxidase activity, reducing thyroid hormone synthesis. Elevated phthalate metabolites are associated with lower free T4 and altered TSH in epidemiological studies.

Phthalates · Urinary Phthalate Metabolites · Plasticizer Exposure Panel

Reference range, optimal functional medicine levels, and why urinary phthalate metabolites quantify exposure to endocrine-disrupting plasticizers found in food packaging, personal care products, and medical tubing, how phthalates suppress testosterone and thyroid hormones, and which exposures are most impactful to reduce.

Environmental ToxinEndocrine Disruptor

Sample TypeUrine (spot)

Key MetabolitesMEHP, MBP, MiNP

FM TargetMinimize exposure

Unitsmcg/g creatinine

← Back to Lab Reference Library

Category: Advanced & Specialty | Also known as: Urinary Phthalate Metabolites, DEHP Metabolites, Phthalate Exposure Testing

1. What This Test Measures

Phthalates are a family of diester compounds used as plasticizers to increase the flexibility and durability of PVC plastics, and as solvents and fixatives in personal care products, fragrances, and pharmaceutical coatings. Because phthalates are not chemically bound to the plastic matrix, they leach continuously into food, water, air, and skin from the products that contain them. The phthalate panel measures urinary metabolites of multiple phthalate compounds, reflecting recent exposure over the prior 24 to 48 hours. Key metabolites tested include MEHP and its oxidized metabolites (from DEHP, the most common high-molecular-weight phthalate), MEP (from DEP, predominant in personal care products), MnBP (from DBP, common in pharmaceutical coatings and cosmetics), MiBP, and MCOP and MCNP (metabolites of replacement phthalates DINP and DIDP).

Phthalates are among the most extensively studied and environmentally pervasive endocrine-disrupting chemicals. The U.S. Centers for Disease Control NHANES surveys consistently find phthalate metabolites detectable in more than 95% of the American population. At current population exposure levels, phthalates have been associated with reduced testosterone and sperm quality, altered thyroid function, increased insulin resistance, endometriosis, precocious puberty, and neurodevelopmental effects in children exposed in utero. Phthalate testing in clinical practice identifies the extent of exposure, guides targeted source reduction, and provides a baseline for monitoring improvement.

2. Major Phthalate Metabolites and Their Primary Sources

Metabolite	Parent Phthalate	Primary Exposure Sources
MEHP, MEHHP, MEOHP	DEHP	Fatty food in PVC packaging, medical tubing, vinyl flooring, soft plastic containers
MEP	DEP	Personal care products (fragrances, shampoo, lotions), nail polish
MnBP, MiBP	DBP, DiBP	Nail polish, pharmaceutical enteric coatings, cosmetics, adhesives
MBzP	BBzP	Vinyl flooring, food contact materials, some personal care products
MCOP, MCNP	DINP, DIDP	Soft PVC replacements for DEHP; children's toys, flooring, car interiors

Results are reported as population percentiles compared to NHANES reference data. Individual metabolites are creatinine-corrected to account for urine dilution. Interpretation focuses on which metabolites are elevated above median population levels and which exposure sources are most likely driving them.

3. Health Effects of Elevated Phthalate Exposure

Testosterone reduction and anti-androgenic effects: MEHP (the primary DEHP metabolite) directly inhibits testicular Leydig cell steroidogenesis by reducing expression of steroidogenic enzymes including StAR, CYP11A1, and 3beta-HSD; DEHP exposure is associated with reduced total testosterone, free testosterone, and SHBG in multiple epidemiological studies; in men with unexplained low testosterone and normal pituitary function, elevated DEHP metabolites should be assessed
Sperm quality and male fertility: phthalate exposure is consistently associated with reduced sperm count, motility, and morphology; DEHP and DBP metabolites are inversely correlated with sperm concentration and total motile sperm count in infertility studies; phthalate testing should be part of the workup for idiopathic male factor infertility
Thyroid hormone disruption: MEHP competes with thyroid hormones for binding to thyroxine-binding globulin (TBG) and transthyretin (TTR), reducing free T4 and T3 transport; phthalate metabolites also inhibit thyroid peroxidase activity; patients with suboptimal thyroid function and borderline labs should have phthalate burden assessed
Insulin resistance and adipogenesis: several phthalate metabolites activate PPAR-gamma, the nuclear receptor that promotes fat cell differentiation and impairs insulin sensitivity; phthalate exposure is associated with higher BMI, visceral adiposity, and insulin resistance independent of diet and physical activity in NHANES data
Endometriosis and female reproductive effects: phthalate exposure promotes inflammation and estrogenic signaling in the endometrium; women with endometriosis show significantly higher urinary phthalate metabolite levels compared to controls; phthalate reduction is a component of integrative endometriosis management
Neurodevelopmental effects (prenatal exposure): maternal phthalate exposure during pregnancy is associated with reduced IQ, increased ADHD symptoms, and behavioral problems in offspring; DEHP and DBP metabolites have the strongest evidence for neurodevelopmental impact, likely through thyroid hormone disruption and direct anti-androgenic effects during critical periods of brain development

4. How to Reduce Phthalate Exposure

Food and Kitchen

Replace plastic food storage with glass, stainless steel, or ceramic
Never heat food in plastic containers; DEHP leaching increases dramatically with heat
Reduce processed and fast food (DEHP from industrial food processing equipment is a major exposure route)
Filter tap water with a carbon or reverse osmosis filter
Choose fresh or frozen foods over canned or plastic-packaged

Personal Care and Home

Switch to fragrance-free personal care products; synthetic fragrance is a major DEP source
Choose nail polish labeled phthalate-free (DBP is common in standard formulations)
Avoid vinyl flooring when possible; use hard wood or tile
Improve indoor air quality with HEPA filtration (phthalates off-gas from vinyl products)
Check pharmaceutical medications for enteric coatings containing DBP

Detoxification Support

Phthalates are metabolized by cytochrome P450 enzymes and glucuronidated for excretion; support phase II detox with cruciferous vegetables, adequate protein, and B vitamins
Glutathione precursors (NAC, glycine) support conjugation and excretion
Adequate hydration accelerates urinary phthalate metabolite excretion
Sauna therapy may support elimination through sweat
Retest after 3 months of exposure reduction to document improvement

5. Related Lab Tests

Free TestosteroneAnti-androgenic phthalate effects on testosterone → Thyroid PanelPhthalate-thyroid hormone interaction assessment → Fasting InsulinPPAR-gamma activation and insulin resistance → DUTCH TestFull hormone and metabolite panel in context of endocrine disruption →

6. Clinical Perspective

Clinical Perspective

Phthalate testing changed how I approach unexplained low testosterone and thyroid dysfunction. When a 38-year-old man comes in with total testosterone of 310 ng/dL, no obvious lifestyle explanation, and a pituitary that looks fine, I now reflexively check phthalate metabolites alongside the standard hormone workup. In probably one in four of those patients, MEHP and the DEHP metabolite cluster are well above the 75th population percentile, and when we work through source reduction together, fatty food in plastic packaging is almost always the dominant driver because it is not the plastic bottle he is drinking from, it is the burrito bowl in the polystyrene container three times a week. Three months of aggressive source reduction can move testosterone 40 to 60 ng/dL without a single peptide or medication. That is a meaningful clinical win from a test that most physicians have never heard of.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

7. Frequently Asked Questions

What are phthalates and where are they found?

Phthalates are chemical plasticizers added to PVC plastic to increase flexibility, and are used as solvents in personal care products, fragrances, and pharmaceutical coatings. The most common exposures come from food in PVC containers, personal care products, soft plastic toys, vinyl flooring, medical tubing, and medications with enteric coatings.

How do phthalates disrupt hormones?

Phthalates and their metabolites act primarily as anti-androgens: they reduce testosterone synthesis by inhibiting testicular Leydig cell steroidogenesis, reduce sperm count and motility, and interfere with luteinizing hormone signaling. They also disrupt thyroid hormone synthesis and transport, and activate PPAR-gamma receptors, contributing to adipogenesis and insulin resistance.

Can phthalates affect thyroid function?

Yes. Several phthalate metabolites, particularly MEHP from DEHP, compete with thyroid hormone for binding to transport proteins (TBG, TTR), reducing free T4 and T3 availability. They also inhibit thyroid peroxidase activity. Elevated phthalate metabolites are associated with lower free T4 and altered TSH in epidemiological studies.

How quickly do phthalate levels decline with reduced exposure?

Phthalates have short half-lives of 8 to 24 hours, so urinary metabolite levels reflect recent exposure rather than accumulated body burden. This means levels decline quickly with exposure reduction. Testing on a typical day for the patient, rather than a restricted-exposure day, gives the most clinically representative result.

What is the most important single phthalate exposure reduction step?

Eliminating fatty food in plastic packaging (including fast food containers, processed foods, and takeout) is typically the largest single intervention for reducing DEHP metabolites, which are the most studied and clinically significant phthalates. Heat dramatically accelerates phthalate leaching, so never microwaving food in plastic and eliminating plastic food packaging for high-fat foods produces the most rapid measurable reduction.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Assess Your Environmental Toxin Burden

Phthalate testing and comprehensive environmental exposure panels are available at The Lamkin Clinic. Schedule a consultation to build your detoxification roadmap.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.